BCR and pachyonychia congenita: For instance, the latest study by Pellegrino et al. employing the Decipher® dataset showed that preoperative PSA blood levels poorly discriminated BCR, the development of metastasis, and PC-specific mortality (PCSM), with an area under the curve (AUC) of 50%, 51.5%, and 50.9%, respectively.